Clearmind Medicine Inc.CMNDNASDAQ
Loading
Year-over-year operating cash flow growth rate
| Period | Value |
|---|---|
| Q4 2025 | -20.57% |
| Q3 2025 | 1.50% |
| Q2 2025 | 18.63% |
| Q1 2025 | -24.38% |
| Q4 2024 | 4.14% |
| Q3 2024 | 4.04% |
| Q2 2024 | 17.06% |
| Q1 2024 | -160.92% |
| Q4 2023 | 45.25% |
| Q3 2023 | -28.65% |
| Q2 2023 | 65.54% |
| Q1 2023 | -16478.64% |
| Q4 2022 | 90.56% |
| Q3 2022 | 82.22% |
| Q2 2022 | 20.31% |
| Q1 2022 | 1.93% |
| Q4 2021 | -332.33% |
| Q3 2021 | 27.73% |
| Q2 2021 | -529.65% |
| Q1 2021 | -24.60% |
| Q4 2020 | 8.00% |
| Q3 2020 | 18.54% |
| Q2 2020 | -10188.55% |
| Q1 2020 | 108.20% |
| Q4 2019 | 37.60% |
| Q3 2019 | -420.68% |
| Q2 2019 | 85.89% |
| Q1 2019 | 51.15% |
| Q4 2018 | -695.70% |
| Q3 2018 | 58.99% |
| Q2 2018 | 36.85% |
| Q1 2018 | -186.42% |
| Q4 2017 | 0.00% |